4baseCare, an Illumina Accelerator backed precision oncology start-up, has raised an investment of USD 2M, led by investors Mount Judi Ventures, growX Ventures, Season Two Ventures, First In Ventures and a few strategic angel investors.
Hitesh Goswami CEO, 4baseCare says, “Access to advanced technology, which can help improve treatment and care should be for everyone. Our vision is to leverage on technology to develop affordable solutions to personalize patient care in Oncology”.
Kshitij Rishi, COO 4baseCare says, “With this capital, we will be increasing the affordability of our genomic test portfolio through research and process efficiency. With our comprehensive solutions and global collaborations, we are confident that we will make precision medicine a standard of cancer care in our country”.
Manu Rikhye, Partner at growX Ventures said “Cancer is the second most common cause of death in India and 4baseCare is leading the charge to fight it. 4baseCare team is leveraging its deep expertise in genomics to enable timely cancer diagnosis, and help identify the most precise targeted therapies to significantly improve patient outcomes. We look forward to working with this exceptional founding team as they work towards making India healthier”.
Sajan Pillai, CEO and Managing Partner of Season Two Ventures said, “Genomics and other data capabilities are now redefining life sciences. Their quest to make precision oncology more affordable and accessible contributes greatly to the growing biotech space in India & globally & we are extremely happy to support them in their journey.”
4baseCare will utilize the funds for expansion of the genomic tests portfolio and for increasing their geographical presence across Asia. Additionally, it will also focus on strengthening its R&D and operations.
Arya has been a part of the Content & Research Team at Hrnxt.com. She is a keen observer of economic developments, emerging businesses, people in business and keeps a tab on latest happenings in the business environment.